Chemoinformaics analysis of 5-O-Methylalloptaeroxylin
| Molecular Weight | 272.3 | nRot | 1 |
| Heavy Atom Molecular Weight | 256.172 | nRig | 17 |
| Exact Molecular Weight | 272.105 | nRing | 3 |
| Solubility: LogS | -4.128 | nHRing | 2 |
| Solubility: LogP | 3.603 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 40.5967 |
| nHD | 0 | BPOL | 22.1273 |
| QED | 0.799 |
| Synth | 2.91 |
| Natural Product Likeliness | 2.483 |
| NR-PPAR-gamma | 0.789 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.985 |
| Pgp-sub | 0.001 |
| HIA | 0.017 |
| CACO-2 | -4.593 |
| MDCK | 0.0000187 |
| BBB | 0.079 |
| PPB | 0.827177 |
| VDSS | 1.06 |
| FU | 0.103319 |
| CYP1A2-inh | 0.932 |
| CYP1A2-sub | 0.946 |
| CYP2c19-inh | 0.761 |
| CYP2c19-sub | 0.812 |
| CYP2c9-inh | 0.657 |
| CYP2c9-sub | 0.844 |
| CYP2d6-inh | 0.816 |
| CYP2d6-sub | 0.847 |
| CYP3a4-inh | 0.643 |
| CYP3a4-sub | 0.598 |
| CL | 3.903 |
| T12 | 0.27 |
| hERG | 0.01 |
| Ames | 0.414 |
| ROA | 0.715 |
| SkinSen | 0.36 |
| Carcinogencity | 0.912 |
| EI | 0.095 |
| Respiratory | 0.928 |
| NR-Aromatase | 0.889 |
| Antiviral | Yes |
| Prediction | 0.716935 |